Resultados de procura - Max S Topp
- Mostrando 1 - 20 Resultados de 69
- Go to Next Page
-
1
-
2
-
3
Multispecific Aspergillus T Cells Selected by CD137 or CD154 Induce Protective Immune Responses Against the Most Relevant Mold Infections por Claudia Stuehler, Justyna Nowakowska, Claudia Bernardini, Max S. Topp, Manuel Battegay, Jakob Passweg, Nina Khanna
Publicado 2014Artigo -
4
Generation of a multipathogen-specific T-cell product for adoptive immunotherapy based on activation-dependent expression of CD154 por Nina Khanna, Claudia Stuehler, Barbara Conrad, Sarah Lurati, Sven Krappmann, Hermann Einsele, Carsten Berges, Max S. Topp
Publicado 2011Artigo -
5
-
6
Rapid generation of combined CMV-specific CD4+ and CD8+ T-cell lines for adoptive transfer into recipients of allogeneic stem cell transplants por Georg Rauser, Hermann Einsele, Christian Sinzger, Dorothee Wernet, Gabriele Kuntz, Mario Assenmacher, John D. Campbell, Max S. Topp
Publicado 2003Artigo -
7
Neurologic adverse events in patients with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab: management and mitigating factors por Anthony S. Stein, Gary J. Schiller, Ramsis Benjamin, Catherine Jia, Alicia Zhang, Min Zhu, Zachary Zimmerman, Max S. Topp
Publicado 2018Artigo -
8
The Natural Human IgM Antibody PAT-SM6 Induces Apoptosis in Primary Human Multiple Myeloma Cells by Targeting Heat Shock Protein GRP78 por Leo Rasche, Johannes Duell, Charlotte Morgner, Manik Chatterjee, Frank Hensel, Andreas Rosenwald, Hermann Einsele, Max S. Topp, Stephanie Brändlein
Publicado 2013Artigo -
9
-
10
Efficient Generation of Antigen-Specific Cytotoxic T Cells Using Retrovirally Transduced CD40-Activated B Cells por Eisei Kondo, Max S. Topp, Hans‐Peter Kiem, Yuichi Obata, Yasuo Morishima, Kiyotaka Kuzushima, Mitsune Tanimoto, Mine Harada, Takashi Takahashi, Yoshiki Akatsuka
Publicado 2002Artigo -
11
Health-related quality of life in adults with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab por Max S. Topp, Zachary Zimmerman, Paul Cannell, Hervé Dombret, Johan Maertens, Anthony S. Stein, Janet Franklin, Qui Tran, Ze Cong, Andre C. Schuh
Publicado 2018Artigo -
12
Frequency of regulatory T cells determines the outcome of the T-cell-engaging antibody blinatumomab in patients with B-precursor ALL por Johannes Duell, Marcus Dittrich, Tanja Bedke, Tobias Mueller, Florian Eisele, Andreas Rosenwald, Leo Rasche, Elena Hartmann, Thomas Dandekar, Hermann Einsele, Max S. Topp
Publicado 2017Artigo -
13
Blinatumomab versus chemotherapy in first salvage or in later salvage for B-cell precursor acute lymphoblastic leukemia por Hervé Dombret, Max S. Topp, Andre C. Schuh, Andrew H. Wei, Simon Durrant, Christopher Larry Bacon, Qui Tran, Zachary Zimmerman, Hagop M. Kantarjian
Publicado 2019Artigo -
14
GRP78-directed immunotherapy in relapsed or refractory multiple myeloma - results from a phase 1 trial with the monoclonal immunoglobulin M antibody PAT-SM6 por Leo Rasche, Johannes Duell, Inês C. Castro, Valentina Dubljevic, Manik Chatterjee, Stefan Knop, Frank Hensel, Andreas Rosenwald, Hermann Einsele, Max S. Topp, Stephanie Brändlein
Publicado 2015Artigo -
15
An Open-Label, Multicenter, Phase I/II Study of JNJ-40346527, a CSF-1R Inhibitor, in Patients with Relapsed or Refractory Hodgkin Lymphoma por Bastian von Tresckow, Franck Morschhauser, Vincent Ribrag, Max S. Topp, Caly Chien, Shobha Seetharam, Regina Aquino, Sonja Kotoulek, Carla J. de Boer, Andreas Engert
Publicado 2015Artigo -
16
-
17
Changes in clinical laboratory parameters and pharmacodynamic markers in response to blinatumomab treatment of patients with relapsed/refractory ALL por Virginie Nägele, Andrea Kratzer, Gerhard Zugmaier, Chris Holland, Youssef Hijazi, Max S. Topp, Nicola Gökbuget, Patrick A. Baeuerle, Peter Kufer, Andreas Wolf, Matthias Klinger
Publicado 2017Artigo -
18
-
19
Fibrin-associated large B-cell lymphoma arising in a cystic lymphangiomatous lesion of the adrenal gland: A case report and overview of the entity por Stefan Kircher, Julia Böck, Katja Maurus, Johannes Düll, Max S. Topp, Anna Katharina Seitz, Christian Kestler, Karen Ernestus, Ioannis Anagnostopoulos, Andreas Rosenwald, Elena Hartmann
Publicado 2025Revisão -
20
Blinatumomab for Acute Lymphoblastic Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation por Anthony S. Stein, Hagop M. Kantarjian, Nicola Gökbuget, Ralf C. Bargou, Mark R. Litzow, Alessandro Rambaldi, Josep‐María Ribera, Alicia Zhang, Zachary Zimmerman, Gerhard Zugmaier, Max S. Topp
Publicado 2019Artigo
Ferramentas de procura:
Materias Relacionadas
Medicine
Internal medicine
Oncology
Biology
Immunology
Leukemia
Refractory (planetary science)
Astrobiology
Blinatumomab
Lymphoblastic Leukemia
Gastroenterology
Chemotherapy
Lymphoma
Physics
Antigen
Transplantation
Genetics
Immune system
Immunotherapy
Minimal residual disease
Adverse effect
CD8
T cell
Biochemistry
Cytotoxic T cell
Hematopoietic stem cell transplantation
In vitro
Acute lymphocytic leukemia
Antibody
Cancer